Neo-Adjuvant treatment in locally advanced thymoma
Conference paper
Abstract
Malignant thymomas are relatively rare neoplasms, representing about 0.2% to 1.5% of all malignancies: the main cause of death is due to locoregional spread and, less frequently, distant metastases [1, 2].
Keywords
Clin Oncol Patient Stage Complete Clinical Response Invasive Thymoma Malignant Thymoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Batata MA, Martini N, Huvos AG (1974) Thymomas-Clinicopathologic features, therapy and prognosis. Cancer 34: 389–396PubMedCrossRefGoogle Scholar
- 2.Verley JM, Hollmann KH (1985) Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 55: 1074–1086PubMedCrossRefGoogle Scholar
- 3.Fornasiero A, Daniele O, Sperandio P (1984) Chemotherapy of invasive or metastatic thymoma: report of 11 cases. Cancer Treat Rep 68: 1205–1210PubMedGoogle Scholar
- 4.Fornasiero A, Daniele O, Ghiotto C (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8 (8): 1419–1423PubMedGoogle Scholar
- 5.Masaoka A, Monden Y, Nakahara K (1981) Follow-up study of thymomas with special references to their clinical stages. Cancer 48: 2485–2492PubMedCrossRefGoogle Scholar
- 6.Fornasiero A, Daniele O, Morandi P (1988) neo-adjuvant chemotherapy in invasive thymoma. Second International Congress on Neo-Adjuvant chemotherapy, Paris 19–21 FebruaryGoogle Scholar
- 7.Monden Y, Nakahara K, Lioka S (1985) Recurrence of thymoma; clinicopathological feature, therapy and prognosis. Ann Thorac Surgery 39: 165–169CrossRefGoogle Scholar
Copyright information
© Springer-Verlag France 1991